From the Editor: A Note on the 2020 Redesign
Editor-in-Chief, Dr. Laura Michaelis introduces the 2020 The Hematologist print redesign, including a better layout, more modern look, and clearer signposts within
Single-cell Genomics Reveals the Cellular Landscape of Bone Marrow Stromal Cells
Drs. Chowdhury and Mead review a study that provides insights into cellular heterogeneity of mouse bone marrow stromal cells, which serve as a comprehensive resource for re
Drs. Kristen O'Dwyer, Jane Liesveld, and Courtney Jones have a conversation about how cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
Dr. Amy DeZern discusses the utility of iron chelation therapy in myelodysplastic syndromes.
Drs. Stephan Moll and Jori May discuss the Joint Commission's guidelines for reducing the likelihood of harm associated with use of anticoagulant therapy.
November/December 2019Volume 16, Issue 6
View all Features articles
View all Diffusion articles
Dr. Silverstein wraps up a year of growth for ASH and previews hemostasis and thrombosis events at the annual meeting.
View all president's column articles
View all Ask the Hematologist articles
View all Clinical Trials Corner articles
View all Mini Review articles
ASH continues to advocate for adequate coverage and reimbursement for chimeric antigen receptor T-cell (CAR-T) therapy. In early August, the Centers for Medicare and Medicaid Services (CMS) finalized policies impacting both reimbursement of and coverage for CAR-T therapy. The final Inpatient Prospective Payment System (IPPS) rule, published on August 2, and the final Decision Memo for CAR T-cell Therapy for Cancers, issued August 7.
ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.
ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2018.
In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology